Hyperuricemia is Associated with the Presence of Metabolically Obese Normal-Weight and Metabolically Healthy Obese Phenotypes

References

• Goday A, Calvo E, Vazquez LA, et al. Prevalence and clinical characteristics of metabolically healthy obese individuals and other obese/non-obese metabolic phenotypes in a working population: results from the Icaria study. BMC Public Health. 2016;16(1):248. doi:10.1186/s12889-016-2921-4.
   PubMedGoogle Scholar
• Primeau V, Coderre L, Karelis AD, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond). 2011;35(7):971–981. doi:10.1038/ijo.2010.216.
   PubMed Web of Science ®Google Scholar
• Appleton SL, Seaborn CJ, Visvanathan R, et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care. 2013;36(8):2388–2394. doi:10.2337/dc12-1971.
   PubMed Web of Science ®Google Scholar
• Ruderman NB, Schneider SH, Berchtold P. The “metabolically-obese,” normal-weight individual. Am J Clin Nutr. 1981;34(8):1617–1621. doi:10.1093/ajcn/34.8.1617.
   PubMed Web of Science ®Google Scholar
• Ding C, Chan Z, Magkos F. Lean, but not healthy: the ‘metabolically obese, normal-weight’ phenotype. Curr Opin Clin Nutr Metab Care. 2016;19(6):408–417. doi:10.1097/MCO.0000000000000317.
   PubMed Web of Science ®Google Scholar
• Huang LO, Loos RJF, Kilpeläinen TO. Evidence of genetic predisposition for metabolically healthy obesity and metabolically obese normal weight. Physiol Genomics. 2018;50(3):169–178. doi:10.1152/physiolgenomics.00044.2017.
   PubMed Web of Science ®Google Scholar
• Ren P, Gao M. Association between metabolic syndrome and the serum uric acid: a Cohort study. Clin Lab. 2018;64(5):719–726. doi:10.7754/Clin.Lab.2017.171037.
   PubMed Web of Science ®Google Scholar
• Ciarla S, Struglia M, Giorgini P, et al. Serum uric acid levels and metabolic syndrome. Arch Physiol Biochem. 2014;120(3):119–122. doi:10.3109/13813455.2014.924145.
   PubMed Web of Science ®Google Scholar
• Cicero AFG, Fogacci F, Giovannini M, et al. Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella heart study. Sci Rep. 2018;8(1):11529. doi:10.1038/s41598-018-29955-w.
   PubMedGoogle Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American Heart Association; World heart federation; International atherosclerosis society; and International association for the study of obesity. Circulation. 2009;120(16):1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National health and nutrition examination survey 2007-2008. Arthritis Rheum. 2011;63(10):3136–3141. doi:10.1002/art.30520.
   PubMed Web of Science ®Google Scholar
• Gamboa-Gómez CI, Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The fat-to-lean mass ratio, a novel anthropometric index, is associated to glucose metabolic disorders. Eur J Intern Med. 2019;63:74–78. doi:10.1016/j.ejim.2019.03.017.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint National committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–1252. doi:10.1161/01.HYP.0000107251.49515.c2.
   PubMed Web of Science ®Google Scholar
• Rocha EPAA, Vogel M, Stanik J, et al. Serum uric acid levels as an indicator for metabolically unhealthy obesity in children and adolescents. Horm Res Paediatr. 2018;90(1):19–27. doi:10.1159/000490113.
   PubMed Web of Science ®Google Scholar
• Ni W, Wang R, Liu Z, et al. Association of serum uric acid with metabolic syndrome and its components: a cross-sectional study in Chinese coastal population. Metab Syndr Relat Disord. 2019;18(2):103–109.doi:10.1089/met.2019.0043.
   PubMed Web of Science ®Google Scholar
• Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol. 2007;293(2):C584–96. doi:10.1152/ajpcell.00600.2006.
   PubMed Web of Science ®Google Scholar
• Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16(12):3553–3562. doi:10.1681/ASN.2005050572.
   PubMed Web of Science ®Google Scholar
• Di Giovine FS, Malawista SE, Thornton E, Duff GW. Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest. 1991;87(4):1375–1381. doi:10.1172/JCI115142.
   PubMed Web of Science ®Google Scholar
• Baldwin W, McRae S, Marek G, et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes. 2011;60(4):1258–1269. doi:10.2337/db10-0916.
   PubMed Web of Science ®Google Scholar
• Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens. 2008;26(2):269–275. doi:10.1097/HJH.0b013e3282f240bf.
   PubMed Web of Science ®Google Scholar
• Wardhana W, Rudijanto A. Effect of uric acid on blood glucose levels. Acta Med Indones. 2018;50:253–256.
   PubMed Web of Science ®Google Scholar
• Cicerchi C, Li N, Kratzer J, et al. Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids. FASEB J. 2014;28(8):3339–3350. doi:10.1096/fj.13-243634.
   PubMed Web of Science ®Google Scholar
• Chen LY, Zhu WH, Chen ZW, et al. Relationship between hyperuricemia and metabolic syndrome. J Zhejiang Univ Sci B. 2007;8(8):593–598. doi:10.1631/jzus.2007.B0593.
   PubMedGoogle Scholar
• Bonora E, Targher G, Zenere MB, et al. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona young men atherosclerosis risk factors study. Int J Obes Relat Metab Disord. 1996;20(11):975–980.
   PubMed Web of Science ®Google Scholar
• Balasubramanian T. Uric acid or 1-methyl uric acid in the urinary bladder increases serum glucose, insulin, true triglyceride, and total cholesterol levels in Wistar rats. ScientificWorldJournal. 2003;3:930–936. doi:10.1100/tsw.2003.90.
   PubMedGoogle Scholar
• Feig DI, Nakagawa T, Karumanchi SA, et al. Hypothesis: uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int. 2004;66(1):281–287. doi:10.1111/j.1523-1755.2004.00729.x.
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 2006;290(3):F625–31. doi:10.1152/ajprenal.00140.2005.
   PubMed Web of Science ®Google Scholar
• Farquharson CA, Butler R, Hill A, Belch JJ, Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation. 2002;106(2):221–226. doi:10.1161/01.CIR.0000022140.61460.1D.
   PubMed Web of Science ®Google Scholar
• Kanbay M, Huddam B, Azak A, et al. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol. 2011;6(8):1887–1894. doi:10.2215/CJN.11451210.
   PubMed Web of Science ®Google Scholar
• Yelken B, Caliskan Y, Gorgulu N, et al. A. Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease. Clin Nephrol. 2012;77(4):275–282. doi:10.5414/CN107352.
   PubMed Web of Science ®Google Scholar